Global Genetic Disease Diagnosis Market 2023 by Company, Regions, Type and Application, Forecast to 2029

  • receipt Report ID : 337957
  • calendar_today Published On: Feb, 2023
  • file_copy Pages: 165
  • list Technology
Buy @ $3500

The Genetic Disease Diagnosis market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Genetic Disease Diagnosis market size will reach USD million in 2029, growing at a CAGR of % over the analysis period.

Market segmentation

Genetic Disease Diagnosis market is split by Type and by Application. For the period 2023-2029, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Robotic Radiosurgery

Usage Of Molecular Target Agents

Others

Market segment by Application, can be divided into

Inherited Disorder Testing

Pharmacogenetic Testing (PGx)

Human Leukocyte Antigen (HLA) Testing

Oncology Testing

Others

Market segment by players, this report covers

Abbott Laboratories

Siemens Healthineers

Roche Diagnostics Corp

Bayer Diagnostics

Sysmex Corporation

Cephide

Bio-Rad Laboratories

Thermo Fisher Scientific

Illumina, Inc

Applied Biosystems

Transgenomic Inc

AutoGenomics

Market segment by regions, regional analysis covers

North America

Europe

Asia-Pacific (China, Japan, South Korea, Rest of Asia-Pacific)

South America

Middle East & Africa

The content of the study subjects, includes a total of 8 chapters:

Chapter 1, to describe Genetic Disease Diagnosis product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Genetic Disease Diagnosis, with recent developments and future plans

Chapter 3, the Genetic Disease Diagnosis competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4, to break the market size data at the region level, with key companies in the key region and Genetic Disease Diagnosis market forecast, by regions, with revenue, from 2023 to 2029.

Chapter 5 and 6, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2023 to 2029.

Chapter 7 and 8, to describe Genetic Disease Diagnosis research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Genetic Disease Diagnosis

1.2 Classification of Genetic Disease Diagnosis by Type

1.2.1 Overview: Global Genetic Disease Diagnosis Market Size by Type: 2022 Versus 2028

1.2.2 Global Genetic Disease Diagnosis Revenue Market Share by Type in 2029

1.2.3 Robotic Radiosurgery

1.2.4 Usage Of Molecular Target Agents

1.2.5 Others

1.3 Global Genetic Disease Diagnosis Market by Application

1.3.1 Overview: Global Genetic Disease Diagnosis Market Size by Application: 2023 Versus 2029

1.3.2 Inherited Disorder Testing

1.3.3 Pharmacogenetic Testing (PGx)

1.3.4 Human Leukocyte Antigen (HLA) Testing

1.3.5 Oncology Testing

1.3.6 Others

1.4 Global Genetic Disease Diagnosis Market Size & Forecast

1.5 Market Drivers, Restraints and Trends

1.5.1 Genetic Disease Diagnosis Market Drivers

1.5.2 Genetic Disease Diagnosis Market Restraints

1.5.3 Genetic Disease Diagnosis Trends Analysis

2 Company Profiles

2.1 Abbott Laboratories

2.1.1 Abbott Laboratories Details

2.1.2 Abbott Laboratories Major Business

2.1.3 Abbott Laboratories Genetic Disease Diagnosis Product and Solutions

2.1.4 Abbott Laboratories Recent Developments and Future Plans

2.2 Siemens Healthineers

2.2.1 Siemens Healthineers Details

2.2.2 Siemens Healthineers Major Business

2.2.3 Siemens Healthineers Genetic Disease Diagnosis Product and Solutions

2.2.4 Siemens Healthineers Recent Developments and Future Plans

2.3 Roche Diagnostics Corp

2.3.1 Roche Diagnostics Corp Details

2.3.2 Roche Diagnostics Corp Major Business

2.3.3 Roche Diagnostics Corp Genetic Disease Diagnosis Product and Solutions

2.3.4 Roche Diagnostics Corp Recent Developments and Future Plans

2.4 Bayer Diagnostics

2.4.1 Bayer Diagnostics Details

2.4.2 Bayer Diagnostics Major Business

2.4.3 Bayer Diagnostics Genetic Disease Diagnosis Product and Solutions

2.4.4 Bayer Diagnostics Recent Developments and Future Plans

2.5 Sysmex Corporation

2.5.1 Sysmex Corporation Details

2.5.2 Sysmex Corporation Major Business

2.5.3 Sysmex Corporation Genetic Disease Diagnosis Product and Solutions

2.5.4 Sysmex Corporation Recent Developments and Future Plans

2.6 Cephide

2.6.1 Cephide Details

2.6.2 Cephide Major Business

2.6.3 Cephide Genetic Disease Diagnosis Product and Solutions

2.6.4 Cephide Recent Developments and Future Plans

2.7 Bio-Rad Laboratories

2.7.1 Bio-Rad Laboratories Details

2.7.2 Bio-Rad Laboratories Major Business

2.7.3 Bio-Rad Laboratories Genetic Disease Diagnosis Product and Solutions

2.7.4 Bio-Rad Laboratories Recent Developments and Future Plans

2.8 Thermo Fisher Scientific

2.8.1 Thermo Fisher Scientific Details

2.8.2 Thermo Fisher Scientific Major Business

2.8.3 Thermo Fisher Scientific Genetic Disease Diagnosis Product and Solutions

2.8.4 Thermo Fisher Scientific Recent Developments and Future Plans

2.9 Illumina, Inc

2.9.1 Illumina, Inc Details

2.9.2 Illumina, Inc Major Business

2.9.3 Illumina, Inc Genetic Disease Diagnosis Product and Solutions

2.9.4 Illumina, Inc Recent Developments and Future Plans

2.10 Applied Biosystems

2.10.1 Applied Biosystems Details

2.10.2 Applied Biosystems Major Business

2.10.3 Applied Biosystems Genetic Disease Diagnosis Product and Solutions

2.10.4 Applied Biosystems Recent Developments and Future Plans

2.11 Transgenomic Inc

2.11.1 Transgenomic Inc Details

2.11.2 Transgenomic Inc Major Business

2.11.3 Transgenomic Inc Genetic Disease Diagnosis Product and Solutions

2.11.4 Transgenomic Inc Recent Developments and Future Plans

2.12 AutoGenomics

2.12.1 AutoGenomics Details

2.12.2 AutoGenomics Major Business

2.12.3 AutoGenomics Genetic Disease Diagnosis Product and Solutions

2.12.4 AutoGenomics Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Genetic Disease Diagnosis Revenue and Share by Players (2023 & 2029)

3.2 Genetic Disease Diagnosis Players Head Office, Products and Services Provided

3.3 Genetic Disease Diagnosis Mergers & Acquisitions

3.4 Genetic Disease Diagnosis New Entrants and Expansion Plans

4 Global Genetic Disease Diagnosis Forecast by Region

4.1 Global Genetic Disease Diagnosis Market Size by Region: 2023 VS 2029

4.2 Global Genetic Disease Diagnosis Market Size by Region, (2023-2029)

4.3 North America

4.3.1 Key Companies of Genetic Disease Diagnosis in North America

4.3.2 Current Situation and Forecast of Genetic Disease Diagnosis in North America

4.3.3 North America Genetic Disease Diagnosis Market Size and Prospect (2023-2029)

4.4 Europe

4.4.1 Key Companies of Genetic Disease Diagnosis in Europe

4.4.2 Current Situation and Forecast of Genetic Disease Diagnosis in Europe

4.4.3 Europe Genetic Disease Diagnosis Market Size and Prospect (2023-2029)

4.5 Asia-Pacific

4.5.1 Key Companies of Genetic Disease Diagnosis in Asia-Pacific

4.5.2 Current Situation and Forecast of Genetic Disease Diagnosis in Asia-Pacific

4.5.3 Asia-Pacific Genetic Disease Diagnosis Market Size and Prospect (2023-2029)

4.5.4 China

4.5.5 Japan

4.5.6 South Korea

4.6 South America

4.6.1 Key Companies of Genetic Disease Diagnosis in South America

4.6.2 Current Situation and Forecast of Genetic Disease Diagnosis in South America

4.6.3 South America Genetic Disease Diagnosis Market Size and Prospect (2023-2029)

4.7 Middle East & Africa

4.7.1 Key Companies of Genetic Disease Diagnosis in Middle East & Africa

4.7.2 Current Situation and Forecast of Genetic Disease Diagnosis in Middle East & Africa

4.7.3 Middle East & Africa Genetic Disease Diagnosis Market Size and Prospect (2023-2029)

5 Market Size Segment by Type

5.1 Global Genetic Disease Diagnosis Market Forecast by Type (2023-2029)

5.2 Global Genetic Disease Diagnosis Market Share Forecast by Type (2023-2029)

6 Market Size Segment by Application

6.1 Global Genetic Disease Diagnosis Market Forecast by Application (2023-2029)

6.2 Global Genetic Disease Diagnosis Market Share Forecast by Application (2023-2029)

7 Research Findings and Conclusion

8 Appendix

8.1 Methodology

8.2 Research Process and Data Source

8.3 Disclaimer

List of Tables

Table 1. Global Genetic Disease Diagnosis Revenue by Type, (USD Million), 2023 VS 2029

Table 2. Global Genetic Disease Diagnosis Revenue by Application, (USD Million), 2023 VS 2029

Table 3. Abbott Laboratories Corporate Information, Head Office, and Major Competitors

Table 4. Abbott Laboratories Major Business

Table 5. Abbott Laboratories Genetic Disease Diagnosis Product and Solutions

Table 6. Siemens Healthineers Corporate Information, Head Office, and Major Competitors

Table 7. Siemens Healthineers Major Business

Table 8. Siemens Healthineers Genetic Disease Diagnosis Product and Solutions

Table 9. Roche Diagnostics Corp Corporate Information, Head Office, and Major Competitors

Table 10. Roche Diagnostics Corp Major Business

Table 11. Roche Diagnostics Corp Genetic Disease Diagnosis Product and Solutions

Table 12. Bayer Diagnostics Corporate Information, Head Office, and Major Competitors

Table 13. Bayer Diagnostics Major Business

Table 14. Bayer Diagnostics Genetic Disease Diagnosis Product and Solutions

Table 15. Sysmex Corporation Corporate Information, Head Office, and Major Competitors

Table 16. Sysmex Corporation Major Business

Table 17. Sysmex Corporation Genetic Disease Diagnosis Product and Solutions

Table 18. Cephide Corporate Information, Head Office, and Major Competitors

Table 19. Cephide Major Business

Table 20. Cephide Genetic Disease Diagnosis Product and Solutions

Table 21. Bio-Rad Laboratories Corporate Information, Head Office, and Major Competitors

Table 22. Bio-Rad Laboratories Major Business

Table 23. Bio-Rad Laboratories Genetic Disease Diagnosis Product and Solutions

Table 24. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors

Table 25. Thermo Fisher Scientific Major Business

Table 26. Thermo Fisher Scientific Genetic Disease Diagnosis Product and Solutions

Table 27. Illumina, Inc Corporate Information, Head Office, and Major Competitors

Table 28. Illumina, Inc Major Business

Table 29. Illumina, Inc Genetic Disease Diagnosis Product and Solutions

Table 30. Applied Biosystems Corporate Information, Head Office, and Major Competitors

Table 31. Applied Biosystems Major Business

Table 32. Applied Biosystems Genetic Disease Diagnosis Product and Solutions

Table 33. Transgenomic Inc Corporate Information, Head Office, and Major Competitors

Table 34. Transgenomic Inc Major Business

Table 35. Transgenomic Inc Genetic Disease Diagnosis Product and Solutions

Table 36. AutoGenomics Corporate Information, Head Office, and Major Competitors

Table 37. AutoGenomics Major Business

Table 38. AutoGenomics Genetic Disease Diagnosis Product and Solutions

Table 39. Global Genetic Disease Diagnosis Revenue (USD Million) by Players (2023 & 2029)

Table 40. Global Genetic Disease Diagnosis Revenue Share by Players (2023 & 2029)

Table 41. Genetic Disease Diagnosis Players Head Office, Products and Services Provided

Table 42. Genetic Disease Diagnosis Mergers & Acquisitions in the Past Five Years

Table 43. Genetic Disease Diagnosis New Entrants and Expansion Plans

Table 44. Global Market Genetic Disease Diagnosis Revenue (USD Million) Comparison by Region (2023 VS 2029)

Table 45. Global Genetic Disease Diagnosis Revenue Market Share by Region (2023-2029)

Table 46. Key Companies of Genetic Disease Diagnosis in North America

Table 47. Current Situation and Forecast of Genetic Disease Diagnosis in North America

Table 48. Key Companies of Genetic Disease Diagnosis in Europe

Table 49. Current Situation and Forecast of Genetic Disease Diagnosis in Europe

Table 50. Key Companies of Genetic Disease Diagnosis in Asia-Pacific

Table 51. Current Situation and Forecast of Genetic Disease Diagnosis in Asia-Pacific

Table 52. Key Companies of Genetic Disease Diagnosis in China

Table 53. Key Companies of Genetic Disease Diagnosis in Japan

Table 54. Key Companies of Genetic Disease Diagnosis in South Korea

Table 55. Key Companies of Genetic Disease Diagnosis in South America

Table 56. Current Situation and Forecast of Genetic Disease Diagnosis in South America

Table 57. Key Companies of Genetic Disease Diagnosis in Middle East & Africa

Table 58. Current Situation and Forecast of Genetic Disease Diagnosis in Middle East & Africa

Table 59. Global Genetic Disease Diagnosis Revenue Forecast by Type (2023-2029)

Table 60. Global Genetic Disease Diagnosis Revenue Forecast by Application (2023-2029)

List of Figures

Figure 1. Genetic Disease Diagnosis Picture

Figure 2. Global Genetic Disease Diagnosis Revenue Market Share by Type in 2029

Figure 3. Robotic Radiosurgery

Figure 4. Usage Of Molecular Target Agents

Figure 5. Others

Figure 6. Genetic Disease Diagnosis Revenue Market Share by Application in 2029

Figure 7. Inherited Disorder Testing Picture

Figure 8. Pharmacogenetic Testing (PGx) Picture

Figure 9. Human Leukocyte Antigen (HLA) Testing Picture

Figure 10. Oncology Testing Picture

Figure 11. Others Picture

Figure 12. Global Genetic Disease Diagnosis Market Size, (USD Million): 2023 VS 2029

Figure 13. Global Genetic Disease Diagnosis Revenue and Forecast (2023-2029) & (USD Million)

Figure 14. Genetic Disease Diagnosis Market Drivers

Figure 15. Genetic Disease Diagnosis Market Restraints

Figure 16. Genetic Disease Diagnosis Market Trends

Figure 17. Abbott Laboratories Recent Developments and Future Plans

Figure 18. Siemens Healthineers Recent Developments and Future Plans

Figure 19. Roche Diagnostics Corp Recent Developments and Future Plans

Figure 20. Bayer Diagnostics Recent Developments and Future Plans

Figure 21. Sysmex Corporation Recent Developments and Future Plans

Figure 22. Cephide Recent Developments and Future Plans

Figure 23. Bio-Rad Laboratories Recent Developments and Future Plans

Figure 24. Thermo Fisher Scientific Recent Developments and Future Plans

Figure 25. Illumina, Inc Recent Developments and Future Plans

Figure 26. Applied Biosystems Recent Developments and Future Plans

Figure 27. Transgenomic Inc Recent Developments and Future Plans

Figure 28. AutoGenomics Recent Developments and Future Plans

Figure 29. Global Genetic Disease Diagnosis Revenue Market Share by Region (2023-2029)

Figure 30. Global Genetic Disease Diagnosis Revenue Market Share by Region in 2029

Figure 31. North America Genetic Disease Diagnosis Revenue (USD Million) and Growth Rate (2023-2029)

Figure 32. Europe Genetic Disease Diagnosis Revenue (USD Million) and Growth Rate (2023-2029)

Figure 33. Asia-Pacific Genetic Disease Diagnosis Revenue (USD Million) and Growth Rate (2023-2029)

Figure 34. South America Genetic Disease Diagnosis Revenue (USD Million) and Growth Rate (2023-2029)

Figure 35. Middle East & Africa Genetic Disease Diagnosis Revenue (USD Million) and Growth Rate (2023-2029)

Figure 36. Global Genetic Disease Diagnosis Market Share Forecast by Type (2023-2029)

Figure 37. Global Genetic Disease Diagnosis Market Share Forecast by Application (2023-2029)

Figure 38. Methodology

Figure 39. Research Process and Data Source